Halliburton Company vs SLB Limited — Stock Comparison
Q·Score Breakdown
6.8
Hold
Overall
7
Buy
Quality
Health
Growth
Valuation
Sentiment
HAL
Healthy balance sheet and financial position.
SLB
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ earnings contracting 14% year-over-year.
Analyst Consensus
BUY
Target $41.64 (-0.7%)
25 analysts
BUY
Target $59.79 (+6.3%)
28 analysts
Fundamentals
HAL
SLB
23.2×
Trailing P/E
24.8×
14.7×
Forward P/E
16.9×
6.9%
Profit Margin
9.3%
15.3%
Gross Margin
17.8%
14.6%
ROE
14.1%
-0.3%
Revenue Growth
2.7%
133.5%
Earnings Growth
-13.8%
0.69
Beta
0.69
—
Price / Book
—
$35.0B
Market Cap
$84.1B
$19 – $42
52-Week Range
$32 – $57
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.